Dr. Jeffrey R. Jay, M.D. »

Vistagen Therapeutics Ord shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6M 1.9M 5.14

More positions owned by Dr. Jeffrey R. Jay, M.D.

Alpine Immune Sciences (ALPN)
Cytokinetics Com New (CYTK)
Urogen Pharma (URGN)
Pliant Therapeutics (PLRX)
Ultragenyx Pharmaceutical (RARE)
Xenon Pharmaceuticals (XENE)
Rapt Therapeutics (RAPT)
Alkermes SHS (ALKS)
Aerovate Therapeutics (AVTE)
Vaxcyte (PCVX)
Evolus (EOLS)
Anaptysbio Inc Common (ANAB)
Immunocore Hldgs Ads (IMCR)
Neurogene (NGNE)
Amicus Therapeutics (FOLD)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Vistagen Therapeutics Ord

BVF
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Nantahala Capital Management
Commodore Capital
Citadel Advisors
Sphera Funds Management
ADAR1 Capital Management
Two Sigma Investments
Goldman Sachs Group
BML Capital Management
Bank Of Montreal
William Blair $ Company
Gts Securities
Citigroup

View all funds holding Vistagen Therapeutics Ord